华仁药业：最大程度维护公司及全体股东的合法权益

Group 1 - The core viewpoint of the article is that Huaren Pharmaceutical (300110) is committed to actively following up on debt resolution progress to maximize the recovery of losses and protect the legal rights of the company and all shareholders [1] Group 2 - The company is responding to investor inquiries on its interactive platform, indicating a proactive approach to managing its financial obligations [1] - The focus is on maintaining the interests of both the company and its shareholders during the debt resolution process [1]